Skip to main content

Table 3 Results of prior HR-HPV testing alone

From: Outcomes of prior cervical cytology and HR-HPV testing in women subsequently diagnosed with CIN1, CIN2/3, and invasive cervical cancer: a 4-year routine clinical experience after implementation of systematic training and quality control programs

HPV test method

CIN1 (n = 713)

CIN2/3 (n = 906)

ICC (n = 220)

Negative (%)

Positive (%)

Negative (%)

Positive (%)

Negative (%)

Positive (%)

HC2 test

46 (14.9)

263 (85.1)

23 (4.6)

476 (95.4)

4 (5.8)

65 (94.2)

Genotyping

97 (24.0)

307 (76.0)

19 (4.7)

388 (95.3)

12 (7.9)

139 (92.1)

Total

143 (20.1)

570 (79.9)

42 (4.6)

864 (95.4)

16 (7.3)

204 (92.7)

  1. HR-HPV high-risk human papillomavirus, CIN cervical intraepithelial neoplasia, ICC invasive cervical cancer, HC2 Hybrid Capture 2